OncLive® to Host State of the Science Summit™ on Treatment of Hematologic Malignancies

Summit will feature distinguished professionals from the Washington University School of Medicine in St. Louis

CRANBURY, N.J.--()--OncLive®, the leading digital provider of resources and information to oncology professionals, presents the latest State of the Science Summit™ on the treatment of hematologic malignancies on Thursday, Oct. 18 from 5 to 9 p.m. (CDT) at the Clayton Plaza Hotel in Missouri. The summit will be co-chaired by experts from the Washington University School of Medicine in St. Louis: Brad S. Kahl, M.D., professor, department of medicine, division of medical oncology and Ravi Vij, M.D., MBA, professor, department of medicine, division of oncology bone marrow transplantation and leukemia.

Designed for community oncologists interested in the treatment of patients with hematologic malignancies. this education program delves into chronic lymphocytic leukemia (CLL), lymphoma, multiple myeloma, chronic myeloid leukemia, acute myeloid leukemia, treatment of myelofibrosis/polycythemia Vera and the latest updates on CAR-T. The event will also feature a peer exchange, which will be followed by a panel discussion and question-and-answer session.

Presenters from the Washington University School of Medicine in St. Louis include:

  • Nancy L Bartlett, M.D., professor, department of medicine, division of medical oncology
  • Armin Ghobadi, M.D., assistant professor, department of medicine, oncology division of bone marrow transplantation and leukemia
  • Meagan A. Jacoby, M.D., assistant professor, department of medicine, oncology division of bone marrow transplantation and leukemia
  • Stephen Oh, M.D., PhD, assistant professor, department of medicine, hematology division, department of pathology and immunology
  • Mark A. Schroeder, M.D., assistant professor, department of medicine, oncology division of bone marrow transplantation and leukemia
  • Geoffrey L. Uy, M.D., associate professor, department of medicine, oncology division of bone marrow transplantation and leukemia

State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.

Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at kcollins@curetoday.com.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

Contacts

OncLive® Media:
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com
or
John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com

Release Summary

OncLive® to Host State of the Science Summit™ on Treatment of Hematologic Malignancies

Contacts

OncLive® Media:
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com
or
John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com